Breast cancer drug capivasertib enters major trial 24 Jun 2020 A major phase III trial of capivasertib, a cancer drug discovered following collaborative work between The Institute of Cancer Research, London, and partners, has begun in breast cancer. Find out more Show/Hide
ASCO 2019: New blood test predicts breast cancer’s return at start of treatment 02 Jun 2019 A new blood test for women with breast cancer can predict how well patients will respond to a new drug right at the start of treatment. Find out more Show/Hide